A mobile colonoscopic unit for lynch syndrome: Trends in surveillance uptake and patient experiences of screening in a developing country

Journal of Genetic Counseling

Volumn 22, Issue 1, 2013, Pages 125-137

  Bruwer, Zandrè ^a   Futter, Merle ^a   Ramesar, Raj ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Developing country; Experience; Genetic counselling; Lynch syndrome; Qualitative research; Surveillance

Indexed keywords

ARTICLE; COLONOSCOPY; DEVELOPING COUNTRY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; METHODOLOGY; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT;

COLONOSCOPY; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DEVELOPING COUNTRIES; HUMANS; MOBILE HEALTH UNITS;

MLCS; MLOWN;

EID: 84873058662     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9523-9     Document Type: Conference Paper

References (65)

1. Aarnio, M., Mecklin, J. P., Aaltonen, L. A., Nystrom-Lahti, M., & Jarvinen, H. J. (1995). Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. International Journal of Cancer, 64(6), 430-433.
2. Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., et al. (1999). Cancer risk in mutation carriers of DNA-mismatch-repair genes. International Journal of Cancer, 81(2), 214-218.
3. Abdel-Rahman, W. M., Mecklin, J. P., & Peltomaki, P. (2006). The genetics of HNPCC: application to diagnosis and screening. Critical Reviews in Oncology/Hematology, 58(3), 208-220.
4. Anderson, D. W., Goldberg, P. A., Algar, U., Felix, R., & Ramesar, R. S. (2007). Mobile colonoscopic surveillance provides quality care for hereditary nonpolyposis colorectal carcinoma families in South Africa. Colorectal Disease, 9(6), 509-514.
5. Annie Yu, H. J., Lin, K. M., Ota, D. M., & Lynch, H. T. (2003). Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treatment Reviews, 29(6), 461-470.
6. Barrow, E., Robinson, L., Alduaij, W., Shenton, A., Clancy, T., Lalloo, F., et al. (2009). Cumulative lifetime incidence of extracolonic cancers in lynch syndrome: a report of 121 families with proven mutations. Clinical Genetics, 75(2), 141-149.
7. Bleiker, E. M., Menko, F. H., Taal, B. G., Kluijt, I., Wever, L. D., Gerritsma, M. A., et al. (2005). Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology, 128(2), 280-287.
8. Colaizzi, P. (1978). Psychological research as the phenomenologist views it. In R. Valle & M. King (Eds.), Existential-phenomenological alternatives for psychology (pp. 6-17). New York: Oxford University Press.
9. Daly, J., Kellehear, A., & Gliksman, M. (1997). The public health researcher: a methodological guide. New York: Oxford University Press.
10. de Jong, A. E., Nagengast, F. M., Kleibeuker, J. H., van de Meeberg, P. C., van Wijk, H. J., Cats, A., et al. (2006). What is the appropriate screening protocol in lynch syndrome? Familial Cancer, 5(4), 373-378.
11. Doak, C. C., Doak, L. G., Friedell, G. H., & Meade, C. D. (1998). Improving comprehension for cancer patients with low literacy skills: strategies for clinicians. A Cancer Journal for Clinicians, 48(3), 151-162.
12. Dunlop, M. G., Farrington, S. M., Carothers, A. D., Wyllie, A. H., Sharp, L., Burn, J., et al. (1997). Cancer risk associated with germline DNA mismatch repair gene mutations. Human Molecular Genetics, 6(1), 105-110.
13. Glanz, K., Grove, J., Lerman, C., Gotay, C., & Le Marchand, L. (1999). Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiology, Biomarkers & Prevention, 8(4 Pt 2), 329-336.
14. Goldberg, P. A., Madden, M. V., Harocopos, C., Felix, R., Westbrook, C., & Ramesar, R. S. (1998). In a resource-poor country, mutation identification has the potential to reduce the cost of family management for hereditary nonpolyposis colorectal cancer. Diseases of the Colon and Rectum, 41(10), 1250-1253.
15. Goldblatt, J., Madden, M. V., Boshoff, P. J., Wallis, C., & Price, S. K. (1990). Hereditary non-polyposis colorectal cancer in a Namaqualand kindred. South African Medical Journal, 77(1), 42-44.
16. Hadley, D. W., Jenkins, J. F., Dimond, E., de Carvalho, M., Kirsch, I., & Palmer, C. G. S. (2004). Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology, 22(1), 39-44.
17. Halbert, C. H., Lynch, H., Lynch, J., Main, D., Kucharski, S., Rustgi, A. K., et al. (2004). Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Archives of Internal Medicine, 164(17), 1881-1887.
18. Harris, M. A., & Byles, J. E. (1997). A survey of screening compliance among first degree relatives of people with colon cancer in New South Wales. Journal of Medical Screening, 4(1), 29-34.
19. Hendriks, Y. M., Wagner, A., Morreau, H., Menko, F., Stormorken, A., Quehenberger, F., et al. (2004). Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology, 127(1), 17-25.
20. Holloway, I. (1997). Basic concepts for qualitative research. Oxford: Blackwell Science.
21. Holloway, I. (2005). Qualitative research in health care. New York: University Press McGraw Hill.
22. Houlston, R. S., Murday, V., Harocopos, C., Williams, C. B., & Slack, J. (1990). Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. British Medical Journal, 301(6748), 366-368.
23. Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomaki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 118(5), 829-834.
24. Järvinen, H. J., Mecklin, J. P., & Sistonen, P. (1995). Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology, 108(5), 1405-1411.
25. Jass, J. R., & Stewart, S. M. (1992). Evolution of hereditary non-polyposis colorectal cancer. Gut, 33(6), 783-786.
26. Jones, L. S., Nicholson, R. W., & Evans, D. A. (2001). Experience with a one-stop colorectal clinic. Journal of the Royal College of Surgeons of Edinburgh, 46(2), 96-97.
27. Kasparian, N. A., Wakefield, C. E., & Meiser, B. (2007). Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. Journal of Genetic Counseling, 16(6), 693-712.
28. Kinney, A. Y., Choi, Y. A., DeVellis, B., Kobetz, E., Millikan, R. C., & Sandler, R. S. (2000). Interest in genetic testing among first-degree relatives of colorectal cancer patients. American Journal of Preventive Medicine, 18(3), 249-252.
29. Kruger, B. J. (2005). Hereditary nonpolyposis colorectal cancer: factors contributing to adherence and non-adherence to surveillance for mutation carriers in rural areas of the northern and western cape. Master's thesis. University of Cape Town, South Africa.
30. Liljegren, A., Lindgren, G., Brandberg, Y., Rotstein, S., Nilsson, B., Hatschek, T., et al. (2004). Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. Journal of Clinical Oncology, 22(9), 1736-1742.
31. Lin, K. M., Shashidharan, M., Thorson, A. G., Ternent, C. A., Blatchford, G. J., Christensen, M. A., et al. (1998). Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. Journal of Gastrointestinal Surgery, 2(1), 67-71.
32. Lindblom, A., Tannergard, P., Werelius, B., & Nordenskjold, M. (1993). Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genetics, 5(3), 279-282.
33. Lynch, H. T., Smyrk, T. C., Watson, P., Lanspa, S. J., Lynch, J. F., Lynch, P. M., et al. (1993a). Genetics, natural history, tumorspectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review. Gastroenterology, 104(5), 1535-1549.
34. Lynch, H. T., Smyrk, T. C., Lanspa, S. J., Jenkins, J. X., Cavalieri, J., & Lynch, J. F. (1993b). Cancer control problems in the lynchsyndromes. Diseases of the Colon and Rectum, 36(3), 254-260.
35. Lynch, H. T., Smyrk, T., & Lynch, J. F. (1998). Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology, 55(2), 103-108.
36. Mack, L. A., Cook, L. S., Temple, W. J., Carlson, L. E., Hilsden, R. J., & Paolucci, E. O. (2009). Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers. Annals of Surgical Oncology, 16(8), 2092-2100.
37. McCann, S., Macauley, D., Barnett, Y., Bunting, B., Bradley, A., Jeffers, L., et al. (2009). Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psycho-Oncology, 18(11), 1208-1215.
38. Mecklin, J. P. (1987). Frequency of hereditary colorectal carcinoma. Gastroenterology, 93(5), 1021-1025.
39. Minichiello, V., Aroni, R., Timewell, E., & Alexander, L. (1990). In depth-interviewing: researching people. Melbourne: Longman Cheshire.
40. Myers, R. E., Trock, B. J., Lerman, C., Wolf, T., Ross, E., & Engstrom, P. F. (1990). Adherence to colorectal cancer screening in an HMO population. Preventive Medicine, 19(5), 502-514.
41. Northam, A. (2010). Colorectal cancer: a neuropsychological approach to non-adherence screening guidelines of individuals with Lynch syndrome in the Western Cape. Master's thesis. University of Cape Town, South Africa.
42. Park, Y. J., Shin, K. H., & Park, J. G. (2000). Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in korea. Clinical Cancer Research, 6(8), 2994-2998.
43. Patton, M. Q. (2002). Qualitative research and evaluation methods (3rd ed.). London: Sage.
44. Peltomaki, P., Aaltonen, L. A., Sistonen, P., Pylkkanen, L., Mecklin, J. P., Jarvinen, H., et al. (1993). Genetic mapping of a locus predisposing to human colorectal cancer. Science, 260(5109), 810-812.
45. Plaschke, J., Engel, C., Kruger, S., Holinski-Feder, E., Pagenstecher, C., Mangold, E., et al. (2004). Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German hereditary nonpolyposis colorectal cancer consortium. Journal of Clinical Oncology, 22(22), 4486-4494.
46. Pylvänäinen, K., Kairaluoma, M., & Mecklin, J. P. (2006). Compliance and satisfaction with long-term surveillance in Finnish HNPCC families. Familial Cancer, 5(2), 175-178.
47. Ramesar, R. S., Madden, M. V., Felix, R., Harocopos, C. J., Westbrook, C. A., Jones, G., et al. (2000). Molecular genetics improves the management of hereditary non-polyposis colorectal cancer. South African Medical Journal, 90(7), 709-714.
48. Richardson, J. L., Danley, K., Mondrus, G. T., Deapen, D., & Mack, T. (1995). Adherence to screening examinations for colorectal cancer after diagnosis in a first-degree relative. Preventive Medicine, 24(2), 166-170.
49. Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Jass, J. R., Khan, P. M., et al. (1997). A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. Journal of the National Cancer Institute, 89(23), 1758-1762.
50. Sarantakos, S. (1993). Social research. Melbourne: Macmillan Press Ltd.
51. Savanhu, T. K. (2005). Haplotyping and estimating the age of the founder mutation identifying familial colorectal cancer. Bachelor of Science thesis. University of Cape Town: South Africa.
52. Stanley, A. J., Gaff, C. L., Aittomaki, A. K., Fabre, L. C., Macrae, F. A., & St John, J. (2000). Value of predictive genetic testing in management of hereditary non-polyposis colorectal cancer (HNPCC). The Medical Journal of Australia, 172(7), 313-316.
53. Stephenson, B. M., Murday, V. A., Finan, P. J., Quirke, P., Dixon, M. F., & Bishop, D. T. (1993). Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut, 34(1), 96-100.
54. Stoffel, E. M., Garber, J. E., Grover, S., Russo, L., Johnson, J., & Syngal, S. (2003). Cancer surveillance is often inadequate in people at high risk for colorectal cancer [Electronic version]. Journal of Medical Genetics, 40(5), e54 [Retrieved October 2011 from PubMed Online database].
55. Stoffel, E. M., Mercado, R. C., Kohlmann, W., Ford, B., Grover, S., Conrad, P., et al. (2010). Prevalence and predictors of appropriate colorectal cancer surveillance in lynch syndrome. The American Journal of Gastroenterology, 105(8), 1851-1860.
56. Stupart, D. A., Goldberg, P. A., Algar, U., & Ramesar, R. (2009). Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Disease, 11(2), 126-130.
57. Sun, W. Y., Basch, C. E., Wolf, R. L., & Li, X. J. (2004). Factors associated with colorectal cancer screening among chinese-americans. Preventive Medicine, 39(2), 323-329.
58. Vasen, H., & Morreau, H. (2002). Familial and hereditary colorectal cancer with emphasis on the hereditary non-polyposis colorectal cancer syndrome. Current Diagnostic Pathology, 8(4), 241-248.
59. Vasen, H. F., Watson, P., Mecklin, J. P., & Lynch, H. T. (1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology, 116(6), 1453-1456.
60. Vernon, S. W., Gritz, E. R., Peterson, S. K., Amos, C. I., Perz, C. A., Baile, W. F., et al. (1997). Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychology, 16(1), 73-86.
61. Voskuil, D. W., Vasen, H. F., Kampman, E., & van't Veer, P. (1997). Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. National collaborative group on HNPCC. International Journal of Cancer, 72(2), 205-209.
62. Wagner, A., van Kessel, I., Kriege, M. G., Tops, C. M., Wijnen, J. T., Vasen, H. F., et al. (2005). Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Familial Cancer, 4(4), 295-300.
63. Watson, P., Lin, K. M., Rodriguez-Bigas, M. A., Smyrk, T., Lemon, S., Shashidharan, M., et al. (1998). Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer, 83(2), 259-266.
64. Watson, P., & Lynch, H. T. (2001). Cancer risk in mismatch repair gene mutation carriers. Familial Cancer, 1(1), 57-60.
65. Weitzman, E. R., Zapka, J., Estabrook, B., & Goins, K. V. (2001). Risk and reluctance: understanding impediments to colorectal cancer screening. Preventive Medicine, 32(6), 502-513.